• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种LRRK2突变作为原PARK8家族帕金森症的病因。

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.

作者信息

Funayama Manabu, Hasegawa Kazuko, Ohta Etsuro, Kawashima Noriko, Komiyama Masaru, Kowa Hisayuki, Tsuji Shoji, Obata Fumiya

机构信息

Division of Clinical Immunology, Kitasato University Graduate School of Medical Sciences, Tokyo, Japan.

出版信息

Ann Neurol. 2005 Jun;57(6):918-21. doi: 10.1002/ana.20484.

DOI:10.1002/ana.20484
PMID:15880653
Abstract

We detected a missense mutation in the kinase domain of the LRRK2 gene in members with autosomal dominant Parkinson's disease of the Japanese family (the Sagamihara family) who served as the basis for the original defining of the PARK8 Parkinson's disease locus. The results of the Sagamihara family, in combination with the unique pathological features characterized by pure nigral degeneration without Lewy bodies, provided us with valuable information for elucidating the protein structure-pathogenesis relationship for the gene product of LRRK2. We did not detect this mutation or other known mutations of the LRRK2 gene in Japanese patients with sporadic Parkinson's disease.

摘要

我们在作为PARK8帕金森病基因座最初定义基础的日本家族(相模原家族)的常染色体显性帕金森病成员中,检测到了LRRK2基因激酶结构域中的一个错义突变。相模原家族的研究结果,结合以无路易小体的单纯黑质变性为特征的独特病理特征,为阐明LRRK2基因产物的蛋白质结构-发病机制关系提供了有价值的信息。我们在散发性帕金森病的日本患者中未检测到该突变或LRRK2基因的其他已知突变。

相似文献

1
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.一种LRRK2突变作为原PARK8家族帕金森症的病因。
Ann Neurol. 2005 Jun;57(6):918-21. doi: 10.1002/ana.20484.
2
[Clinical molecular genetics for PARK8 (LRRK2)].PARK8(LRRK2)的临床分子遗传学
Brain Nerve. 2007 Aug;59(8):839-50.
3
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.家族性帕金森病:对具有不同临床病理结果的相模原 PARK8(I2020T)原始家系的研究。
Parkinsonism Relat Disord. 2009 May;15(4):300-6. doi: 10.1016/j.parkreldis.2008.07.010. Epub 2008 Sep 18.
4
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.编码富含亮氨酸重复激酶2(dardarin,PARK8)的基因发生突变会导致家族性帕金森病:临床、病理、嗅觉及功能影像学和遗传学数据。
Brain. 2005 Dec;128(Pt 12):2786-96. doi: 10.1093/brain/awh667. Epub 2005 Nov 4.
5
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.LRRK2基因的突变会导致具有多形性病理特征的常染色体显性帕金森病。
Neuron. 2004 Nov 18;44(4):601-7. doi: 10.1016/j.neuron.2004.11.005.
6
Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.携带LRRK2基因相关帕金森病家族的临床和病理特征。
J Neural Transm Suppl. 2006(70):221-9. doi: 10.1007/978-3-211-45295-0_34.
7
A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.俄罗斯家族性和散发性帕金森病中常见的富含亮氨酸重复序列激酶2基因突变。
Eur J Neurol. 2007 Apr;14(4):413-7. doi: 10.1111/j.1468-1331.2007.01685.x.
8
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.由LRRK2引起的帕金森病的临床及正电子发射断层扫描
Ann Neurol. 2005 Mar;57(3):453-6. doi: 10.1002/ana.20401.
9
PARK8 LRRK2 parkinsonism.PARK8型富亮氨酸重复激酶2相关性帕金森病
Curr Neurol Neurosci Rep. 2006 Jul;6(4):287-94. doi: 10.1007/s11910-006-0020-0.
10
Common variants of LRRK2 are not associated with sporadic Parkinson's disease.LRRK2的常见变异与散发性帕金森病无关。
Ann Neurol. 2005 Dec;58(6):905-8. doi: 10.1002/ana.20664.

引用本文的文献

1
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.帕金森病中的认知衰退:从临床表型到遗传背景
Biomedicines. 2025 Jul 2;13(7):1624. doi: 10.3390/biomedicines13071624.
2
Recent advances in targeting LRRK2 for Parkinson's disease treatment.针对帕金森病治疗靶向亮氨酸丰富重复激酶2(LRRK2)的最新进展。
J Transl Med. 2025 Jul 8;23(1):754. doi: 10.1186/s12967-025-06354-0.
3
Neuropathological examination of 12 cases of familial Parkinson's disease with LRRK2 I2020T mutation including tau and TDP-43 pathology.
对12例携带LRRK2 I2020T突变的家族性帕金森病患者进行神经病理学检查,包括tau蛋白和TDP - 43病理学检查。
J Neurol. 2025 Jun 9;272(7):450. doi: 10.1007/s00415-025-13148-3.
4
Contribution of Genetics to Parkinson's Disease and Future Prospects.遗传学对帕金森病的贡献及未来展望。
Juntendo Med J. 2025 Apr 3;71(2):76-81. doi: 10.14789/ejmj.JMJ24-0052-P. eCollection 2025.
5
Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson's disease.α-突触核蛋白寡聚体在与富亮氨酸重复激酶2(LRRK2)相关的帕金森病中的广泛分布。
Acta Neuropathol. 2025 May 2;149(1):42. doi: 10.1007/s00401-025-02872-9.
6
Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease.帕金森病中LRRK2变异体临床和基因谱的最新MDSGene综述。
NPJ Parkinsons Dis. 2025 Feb 17;11(1):30. doi: 10.1038/s41531-025-00881-9.
7
Widespread Distribution of α-Synuclein Oligomers in -related Parkinson's Disease.α-突触核蛋白寡聚体在帕金森病中的广泛分布
bioRxiv. 2024 Dec 20:2024.12.18.629265. doi: 10.1101/2024.12.18.629265.
8
The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson's disease.p.Gly2019Ser是埃及家族性和散发性帕金森病患者中常见的LRRK2致病变体。
NPJ Parkinsons Dis. 2024 Nov 6;10(1):215. doi: 10.1038/s41531-024-00826-8.
9
p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central Europe.p.L1795F LRRK2变异是中欧帕金森病的常见病因。
Res Sq. 2024 May 29:rs.3.rs-4378197. doi: 10.21203/rs.3.rs-4378197/v1.
10
RedOx regulation of LRRK2 kinase activity by active site cysteines.活性位点半胱氨酸对LRRK2激酶活性的氧化还原调节。
NPJ Parkinsons Dis. 2024 Apr 3;10(1):75. doi: 10.1038/s41531-024-00683-5.